The Institut national de la santé et de la recherche médicale (Inserm) is a leading French research organization dedicated to advancing health and medical research. With an impressive budget of 1.176 billion euros for 2024, Inserm supports approximately 350 laboratories across France, driving innovations in various medical fields including neuroscience, immunology, and cancer research.

Inserm focuses on a broad array of health-related issues, emphasizing both fundamental and applied research. Their initiatives range from studying the early symptoms of neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) to developing human organoids for infertility research. The organization is also at the forefront of public health campaigns and awareness days, such as the National Hearing Day, highlighting critical health topics and encouraging community engagement.

Through dedicated press services and resources, Inserm provides timely updates on their discoveries and initiatives, making vital research accessible and relevant to journalists, healthcare professionals, and the general public.